RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 LAI Improves Pulmonary Function in CF
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 11
SP 22
OP 23
DO 10.1177/155989771411016
UL http://mdc.sagepub.com/content/14/11/22.2.abstract
AB Treatment of chronic bronchopulmonary infection by Pseudomonas aeruginosa in patients with cystic fibrosis (CF) with liposomal amikacin for inhalation (LAI) resulted in improved pulmonary function and decreased P aeruginosa sputum concentration in an interim analysis. This article discusses interim data from the Long Term Safety and Tolerability of Open-Label Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients With Chronic Infection due to Pseudomonas aeruginosa trial [CLEAR-110; NCT01316276; Bilton D et al. Am J Respir Crit Care Med 2014].